From: Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa
Countries | Patients (n) | Mean doses (mL [range]) | # deaths (CFR) | Supportive measures* | Reference |
---|---|---|---|---|---|
Guinea | 26 | 25 ml | 4 (15%) | No | Group 2 this study |
[10–60] | |||||
Guinea | 17 | 40 mL | 3 (18%) | No | Group 3 this study |
[40–60] | |||||
India | 28 | 150 mL | 0 | VS | [16] |
India | 27 | 600 mL | 3 (11%) | VS | [16] |
[300–1.600] | |||||
Sri Lanka | 87 | > 100 mL | 5 (6%) | VS | [17] |
[100–200] | |||||
Sri Lanka | 25 | 100 mL | 2 (8%)§ | VS | [18] |
[80–200] | |||||
India | 37 | 150 mL | 11 (22%)* | VS; AC | [19] |
Taiwan | 22 | 30 mL | 0 | VS | [20] |
[10–100] | |||||
Papua New Guinea | 139 | 50 mL | 6 (4.3%) | VS | [13] |
Papua New Guinea | 31 | 25 mL | 0 | VS; AC | [13] |
India | 14 | 60 mL | 1 (7%) | VS | [21] |
India | 12 | 120 mL | 0 | VS | [21] |
Thailand | 68 | 100 mL | 0 | VS | [22] |
India | 86 | 510 mL | 3 (3.5%) | VS | [23] |
[50–1900] | |||||
Papua New Guinea | 156 | 50 mL | 3 (1.9%) | VS | [14] |
Vietnam | 42 | 50 mL | 0 | VS | [24] |
[50–100] | |||||
Thailand | 85 | 40 mL | 1 (1%) | VS | [25] |
[10–200] |